Yang Wang

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Cell Cycle Arrest

Transcription Factor

Top Venues

The Journal of pharmacy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Wang, Ge Bai, Shanshan Mu, Fenglian Zhang, Yan Wang
Indobufen alleviates ischemic stroke injury by regulating transcription factor NRF2 and inhibiting ATG5 expression. The Journal of pharmacy and pharmacology (2024)
Yang Wang, Ge Bai, Shanshan Mu, Fenglian Zhang, Yan Wang
Indobufen alleviates ischemic stroke injury by regulating transcription factor NRF2 and inhibiting ATG5 expression. The Journal of pharmacy and pharmacology 76 (7) (2024)